|
1
|
Buekki J: Pancreatic adenocarcinoma. N
Engl J Med. 371:2139–2140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iacobuzio-Donahue CA and Herman JM:
Autophagy, p53, and pancreatic cancer. N Engl J Med. 370:1352–1353.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Viale A, Pettazzoni P, Lyssiotis CA, Ying
H, Sanchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V,
et al: Oncogene ablation-resistant pancreatic cancer cells depend
on mitochondrial function. Nature. 514:628–632. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin S, Mu Y, Wang X, Liu Z, Wan L, Xiong
Y, Zhang Y, Zhou L and Li L: Overexpressed RACK1 is positively
correlated with malignant degree of human colorectal carcinoma. Mol
Biol Rep. 41:3393–3399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu L, Lu F, Wang Y, Liu Y, Liu D, Jiang Z,
Wan C, Zhu B, Gan L, Wang Y, et al: RACK1, a novel
hPER1-interacting protein. J Mol Neurosci. 29:55–63. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho IR, Kaowinn S, Moon J, Soh J, Kang HY,
Jung CR, Oh S, Song H, Koh SS and Chung YH: Oncotropic H-1
parvovirus infection degrades HIF-1alpha protein in human
pancreatic cancer cells independently of VHL and RACK1. Int J
Oncol. 46:2076–2082. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sato T, Takahashi H, Hatakeyama S, Iguchi
A and Ariga T: The TRIM-FLMN protein TRIM45 directly interacts with
RACK1 and negatively regulates PKC-mediated signaling pathway.
Oncogene. 34:1280–1291. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng D, Qian W, Wang Y, Meng M, Wei L, Li
Z, Kang L, Peng J and Xia Q: Nuclear import of transcription factor
BR-C is mediated by its interaction with RACK1. PloS One.
9:e1091112014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Omosigho NN, Swaminathan K, Plomann M,
Mueller-Taubenberger A, Noegel AA and Riyahi TY: The Dictyostelium
discoideum RACK1 orthologue has roles in growth and development.
Cell Commun Signal. 12:372014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Waddell N, Pajic M, Patch AM, Chang DK,
Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, et al:
Whole genomes redefine the mutational landscape of pancreatic
cancer. Nature. 518:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Junttila MR and de Sauvage FJ: Influence
of tumour micro-environment heterogeneity on therapeutic response.
Nature. 501:346–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng F, Li W, Li C, Gao Z, Guo K and Song
S: CCL18 promotes epithelial-mesenchymal transition, invasion and
migration of pancreatic cancer cells in pancreatic ductal
adenocarcinoma. Int J Oncol. 46:1109–1120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang LJ, Wang KB, Liu LS, Chen LZ, Peng
BG, Liang LJ, Li Z, Xue L, Li W and Xia JT: Overexpression of
GOLPH3 is associated with poor prognosis and clinical progression
in pancreatic ductal adenocarcinoma. BMC Cancer. 14:5712014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang YT, Wu CC, Shyr YM, Chen TC, Hwang
TL, Yeh TS, Chang KP, Liu HP, Liu YL, Tsai MH, et al:
Secretome-based identification of ULBP2 as a novel serum marker for
pancreatic cancer detection. PloS One. 6:e200292011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oron Y: Integrin-based therapy of
pancreatic adenocarcinoma: Current status and future perspectives.
Minerva Gastroenterol Dietol. 61:71–86. 2015.PubMed/NCBI
|
|
19
|
Strobel O, Hinz U, Gluth A, Hank T,
Hackert T, Bergmann F, Werner J and Buchler MW: Pancreatic
adenocarcinoma: Number of positive nodes allows to distinguish
several N categories. Ann Surg. 261:961–969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bever KM, Sugar EA, Bigelow E, Sharma R,
Laheru D, Wolfgang CL, Jaffee EM, Anders RA, De Jesus-Acosta A and
Zheng L: The prognostic value of stroma in pancreatic cancer in
patients receiving adjuvant therapy. HPB (Oxford). 17:292–298.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui J, Chen Y, Wang HY and Wang RF:
Mechanisms and pathways of innate immune activation and regulation
in health and cancer. Hum Vaccin Immunother. 10:3270–3285. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Myklebust LM, Horvli O and Raae AJ: RACK1
(receptor for activated C-kinase 1) interactions with spectrin
repeat elements. J Mol Recognit. 28:49–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Campagne C, Jule S, Alleaume C, Bernex F,
Ezagal J, Chateau-Joubert S, Estrada M, Aubin-Houzelstein G,
Panthier JJ and Egidy G: Canine melanoma diagnosis: RACKI as a
potential biological marker. Vet Pathol. 50:1083–1090. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long
LY, Li G, Ji XD, Shi S, Guan DX, et al: RACK1 suppresses gastric
tumorigenesis by stabilizing the beta-Catenin destruction complex.
Gastroenterology. 142:812.e15–823.e15. 2012. View Article : Google Scholar
|
|
25
|
Ruan Y and Gu J: O-GlcNAc modification of
ribosomal RACK1 enhances hypoxia-induced epithelial-mesenchymal
transition in hepatocellular carcinoma. Glycobiology. 23:1345.
2013.
|
|
26
|
Choi YY, Lee SY, Lee WK, Jeon HS, Lee EB,
Lee HC, Choi JE, Kang HG, Lee EJ, Bae EY, et al: RACK1 is a
candidate gene associated with the prognosis of patients with early
stage non-small cell lung cancer. Oncotarget. 6:4451–4466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mamidipudi V and Cartwright CA: A novel
pro-apoptotic function of RACK1: Suppression of Src activity in the
intrinsic and Akt pathways. Oncogene. 28:4421–4433. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saito A, Fujii G, Sato Y, Gotoh M,
Sakamoto M, Toda G and Hirohashi S: Detection of genes expressed in
primary colon cancers by in situ hybridisation: Overexpression of
RACK 1. Mol Pathol. 55:34–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
